StockComparison Logo
vs

ESLA vs RENB

Comparison between Estrella Immunopharma Inc (ESLA, Company) and (RENB, Company).

ESLA vs RENB - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
ESLA
$32M
RENB
$32M
Max Drawdown
ESLA
96.58%
RENB
N/A
Sharpe Ratio
Winner
ESLA
0.38
RENB
0.00
5Y Beta
ESLA
0.49
RENB
N/A
Industry
ESLA
Biotechnology
RENB
N/A
P/E Ratio
Winner
ESLA
-1.95
RENB
-0.18
PEG Ratio
ESLA
-0.03
RENB
N/A
Debt to Equity
Winner
ESLA
0.00%
RENB
0.28%
Free Cash Flow Yield
ESLA
-25.01%
Winner
RENB
-22.54%
P/S Ratio
ESLA
N/A
RENB
138.82
P/B Ratio
ESLA
4.13
Winner
RENB
-2.45

ESLA vs RENB - Historical Returns

Returns include dividend reinvestment.

1M
ESLA
-20.41%
RENB
N/A
3M
ESLA
-50.63%
RENB
N/A
6M
ESLA
-22.77%
RENB
N/A
1Y
ESLA
-17.85%
RENB
N/A
5Y(CAGR)
ESLA
-40.55%
RENB
N/A
Max(CAGR)
ESLA
-40.55%
Winner
RENB
+51169209385514262528.00%

ESLA vs RENB - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

YearESLARENB
2026-43.88%N/A
2025+39.27%+11.81%
2024+4.35%N/A
2023-89.17%N/A
2022+3.83%N/A
2021+1.64%N/A

ESLA vs RENB Drawdown Comparison

The maximum drawdown for ESLA was -96.58%, occurring on Nov 1, 2024. This drawdown has not yet recovered.

The current ESLA drawdown is -96.33%.

RankESLARENB
#1-96.58%
Sep 1, 2023 - Nov 1, 2024
N/A
#2-35.78%
Aug 1, 2023 - Sep 1, 2023
N/A
#3-9.91%
Jul 17, 2023 - Aug 1, 2023
N/A
#4-4.95%
May 25, 2022 - Jan 30, 2023
N/A
#5-4.36%
May 16, 2023 - Jul 14, 2023
N/A
#6-2.72%
Jan 31, 2023 - Feb 13, 2023
N/A
#7-2.46%
Jan 4, 2022 - May 25, 2022
N/A
#8-2.24%
Feb 13, 2023 - May 9, 2023
N/A
#9-1.30%
Nov 26, 2021 - Jan 4, 2022
N/A
#10-0.46%
May 12, 2023 - May 16, 2023
N/A
#11-0.40%
Oct 28, 2021 - Nov 26, 2021
N/A
#12-0.31%
Sep 21, 2021 - Sep 28, 2021
N/A
#13-0.20%
Sep 29, 2021 - Oct 27, 2021
N/A

Correlation

Correlation between ESLA and RENB is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.

0.00
-101

Select Stocks to Compare